Jennison Associates Portfolio holdings
Jennison Associates, founded in 1969 and headquartered in New York City, is a global investment management firm managing over $194 billion in assets as of late 2024, specializing in active equity and fixed-income strategies. A subsidiary of PGIM, the asset management arm of Prudential Financial, Jennison serves a diverse client base—including institutions, sub-advisory clients, public plans, endowments, and corporations—with a focus on fundamental research, bottom-up portfolio construction, and high-conviction investing. Known for its equity expertise across styles, geographies, and market capitalizations, as well as investment-grade fixed-income offerings, the firm employs seasoned portfolio managers averaging 29 years of industry experience and 16 years with Jennison. With additional offices in Boston and a culture emphasizing intellectual rigor and long-term client outcomes, Jennison has built a reputation for excellence and stability in the investment management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Perrigo
PRGO
|
+$672M |
| 2 |
Merck
MRK
|
+$608M |
| 3 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$384M |
| 4 |
Las Vegas Sands
LVS
|
+$378M |
| 5 |
TFCFA
Twenty-First Century Fox, Inc. Class A
TFCFA
|
+$303M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Ralph Lauren
RL
|
+$518M |
| 2 |
eBay
EBAY
|
+$474M |
| 3 |
Estee Lauder
EL
|
+$435M |
| 4 |
Goldman Sachs
GS
|
+$323M |
| 5 |
TechnipFMC
FTI
|
+$304M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.39% |
| 2 | Consumer Discretionary | 14.31% |
| 3 | Technology | 11.26% |
| 4 | Communication Services | 11.24% |
| 5 | Energy | 10.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
A.O. Smith
AOS
$8.21B
| $609K | ﹤0.01% |
26,458
-344
| -1% | -$8.38K |
|
|
SREV
677
DELISTED
ServiceSource International, Inc.
SREV
| $605K | ﹤0.01% |
71,624
-619
| -0.9% | -$5.2K |
|
678
West Pharmaceutical
WST
$23.7B
| $602K | ﹤0.01% |
13,664
-178
| -1% | -$8.38K |
|
679
Newmont
NEM
$135B
| $600K | ﹤0.01% |
25,605
+11,086
| +76% | +$264K |
|
680
Trane Technologies
TT
$98.8B
| $598K | ﹤0.01% |
+10,441
| New | +$622K |
|
|
NAVG
681
DELISTED
Navigators Group Inc
NAVG
| $582K | ﹤0.01% |
18,948
-174
| -0.9% | -$5.3K |
|
682
Renasant Corp
RNST
$3.76B
| $572K | ﹤0.01% |
19,681
-183
| -0.9% | -$5.35K |
|
683
SPS Commerce
SPSC
$3.06B
| $553K | ﹤0.01% |
18,006
-164
| -0.9% | -$5.37K |
|
|
NS
684
DELISTED
NuStar Energy L.P.
NS
| $551K | ﹤0.01% |
+10,024
| New | +$513K |
|
|
WES
685
DELISTED
Western Gas Partners Lp
WES
| $546K | ﹤0.01% |
+8,245
| New | +$513K |
|
|
APOL
686
DELISTED
Apollo Education Group Inc Class A
APOL
| $542K | ﹤0.01% |
+15,836
| New | +$514K |
|
687
Generac Holdings
GNRC
$10.8B
| $540K | ﹤0.01% |
9,163
-9,008
| -50% | -$492K |
|
688
Zumiez
ZUMZ
$307M
| $536K | ﹤0.01% |
+22,124
| New | +$518K |
|
689
Sunoco
SUN
$14.1B
| $533K | ﹤0.01% |
+15,177
| New | +$529K |
|
690
Genesis Energy
GEL
$1.96B
| $528K | ﹤0.01% |
+9,733
| New | +$525K |
|
|
TGI
691
DELISTED
Triumph Group
TGI
| $526K | ﹤0.01% |
8,140
-106
| -1% | -$7.26K |
|
|
ANN
692
DELISTED
ANN INC
ANN
| $523K | ﹤0.01% |
+12,605
| New | +$450K |
|
693
Tenaris
TS
$27.2B
| $511K | ﹤0.01% |
11,548
+5,764
| +100% | +$250K |
|
|
OMN
694
DELISTED
OMNOVA Solutions Inc.
OMN
| $502K | ﹤0.01% |
48,389
-458
| -0.9% | -$4.37K |
|
|
DRIV
695
DELISTED
DIGITAL RIVER INC.
DRIV
| $500K | ﹤0.01% |
28,707
-250
| -0.9% | -$4.43K |
|
696
Omnicell
OMCL
$1.51B
| $493K | ﹤0.01% |
17,229
-160
| -0.9% | -$4.38K |
|
697
Casey's General Stores
CASY
$28B
| $483K | ﹤0.01% |
7,150
-61
| -0.8% | -$4.13K |
|
|
QLGC
698
DELISTED
QLOGIC CORP
QLGC
| $478K | ﹤0.01% |
37,508
-340
| -0.9% | -$3.98K |
|
|
FNFG
699
DELISTED
FIRST NIAGARA FINANCIAL GROUP INC
FNFG
| $474K | ﹤0.01% |
50,109
-3,261
| -6% | -$30.3K |
|
700
Option Care Health
OPCH
$3.58B
| $457K | ﹤0.01% |
16,369
-143
| -0.9% | -$4.42K |
|
Similar funds
Jennison Associates's Q1 2014 Portfolio in Review
As of Q1 2014, Jennison Associates held 826 positions worth $105B, up 2.6% from $102B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Jennison Associates's Q1 2014 filing shows 122 new, 275 increased, 321 reduced and 94 closed positions. Its largest new stake was Perrigo: 4,257,843 shares worth $659M. The largest sale was Ralph Lauren, an estimated $518M.
By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Consumer Discretionary and Technology.
- Jennison Associates's largest Q1 2014 buy was Perrigo: 4,257,843 shares worth $659M.
- Jennison Associates added most to Merck in Q1 2014, an estimated $608M increase.
- Jennison Associates's biggest Q1 2014 reduction was Estee Lauder, cutting an estimated $435M.
- Jennison Associates fully exited Ralph Lauren in Q1 2014, selling an estimated $518M.
- Jennison Associates's ten largest holdings make up 18% of its $105B portfolio in Q1 2014.
- Jennison Associates opened 122 new positions and closed 94 in Q1 2014.
- Jennison Associates's portfolio value rose 2.6% quarter-over-quarter to $105B.
Based on Jennison Associates's 13F filing for Q1 2014, filed 7 May 2014.